Ernst & Young LLP (EY US) today announced that Dea Belazi, president & CEO, AscellaHealth, was named an Entrepreneur Of The Year^® 2023 National finalist. Belazi was selected from a pool of 224 Entrepreneur Of The Year 2023 regional award winners from 197 companies across the US. Entrepreneur Of The Year was created to honor those audacious entrepreneurs who dare to reimagine what’s possible and develop products and solutions that disrupt markets, revolutionize industries and transform lives. Now in its 37th year, it is celebrated as one of the most respected business award programs in the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231116902078/en/

Dea Belazi, president & CEO, AscellaHealth, has been named Entrepreneur Of The Year® 2023 National finalist. (Photo: Business Wire)

Belazi’s recognition underscores AscellaHealth’s unwavering commitment to improve patient care and enhance access to specialty drugs and cell and gene therapies for rare diseases and complex conditions, with tailor-made solutions to streamline the commercialization of specialty medications, improve affordability of expensive therapies, and optimize clinical health outcomes. The team’s success demonstrates the effectiveness of AscellaHealth’s tech-enabled, customized end-to-end solutions for pharmaceutical manufacturers as well as payers, providers and patients. As a single-source partner, AscellaHealth provides comprehensive capabilities across the entire pharmaceutical product lifecycle and beyond, from pre-commercialization, market access and clinical trial support to launch, exclusive distribution, fulfillment and outcomes tracking.

Belazi was selected by a panel of independent judges made up of entrepreneurs and other notable business leaders from across the US. The candidates were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes.

“The AscellaHealth team embodies the true spirit of entrepreneurship, helping to successfully bring to market innovative therapies for complex, chronic conditions and rare diseases,” says Belazi. “Our top-down commitment to patient care and innovation benefits patients, life sciences manufacturers, payers and providers resulting in optimization of the specialty pharmaceutical and healthcare ecosystem. As true innovators, AscellaHealth is proud to proactively address the unmet needs of clients and patients worldwide.”

Since 1986, Entrepreneur Of The Year has celebrated entrepreneurs whose drive, innovative spirit and creativity have fueled their companies’ success, revolutionized their industries and positively impacted their communities. The National finalists and winners were announced during a celebration held at the Strategic Growth Forum^®, one of the nation’s most prestigious gatherings of high-growth, market-leading companies. Learn more about the Entrepreneur Of The Year 2023 National finalists and winners at https://www.ey.com/en_us/entrepreneur-of-the-year/meet-the-winners-and-finalists.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards include presenting sponsors PNC Bank, SAP America and the Ewing Marion Kauffman Foundation.

About Entrepreneur Of The Year^®

Entrepreneur Of The Year^® is the world’s most prestigious business awards program for ambitious entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the World Entrepreneur Of The Year title. Visit ey.com/us/eoy.

About EY

EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets.

Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate.

Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.

Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US.

About AscellaHealth LLC

AscellaHealth, a global healthcare and specialty pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, including Deloitte Technology Fast 500™ and Inc. 5000, AscellaHealth’s customized, patient-centric approach is built upon proprietary technology processes for end-to-end solutions to streamline the commercialization of specialty medications and proactively address unmet client needs, optimize clinical health outcomes and improve the quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit www.AscellaHealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231116902078/en/